NCT04880356 Longitudinal Study of Ultra-rare Inherited Metabolic and Degenerative Neurological Diseases.
| NCT ID | NCT04880356 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta |
| Condition | Inherited Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2021-03-01 |
| Primary Completion | 2031-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2021-03-01 with a primary completion date of 2031-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
General aim of the study is the improvement of the clinical knowledge of ultra-rare inherited metabolic and degenerative neurological diseases (prevalence less than 5:100,000) in adulthood through the systematic longitudinal collection of clinical, laboratory and instrumental data.
Eligibility Criteria
Inclusion Criteria: * Age \>= 18 years * Subjects with ultra-rare inherited degenerative and metabolic neurological diseases * Subjects with undiagnosed neurological diseases (when supposed to be inherited) Exclusion Criteria: * none
Contact & Investigator
Frequently Asked Questions
Who can join the NCT04880356 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Inherited Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04880356 currently recruiting?
Yes, NCT04880356 is actively recruiting participants. Contact the research team at ettore.salsano@istituto-besta.it for enrollment information.
Where is the NCT04880356 trial being conducted?
This trial is being conducted at Milan, Italy.
Who is sponsoring the NCT04880356 clinical trial?
NCT04880356 is sponsored by Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta. The trial plans to enroll 100 participants.